These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 38789815)
21. Biosynthetic gene clusters with biotechnological applications in novel Antarctic isolates from Actinomycetota. Bruna P; Núñez-Montero K; Contreras MJ; Leal K; García M; Abanto M; Barrientos L Appl Microbiol Biotechnol; 2024 May; 108(1):325. PubMed ID: 38717668 [TBL] [Abstract][Full Text] [Related]
22. Artificial chromosomes to explore and to exploit biosynthetic capabilities of actinomycetes. Alduina R; Gallo G J Biomed Biotechnol; 2012; 2012():462049. PubMed ID: 22919271 [TBL] [Abstract][Full Text] [Related]
23. Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes? Krause J Molecules; 2021 Sep; 26(18):. PubMed ID: 34576921 [TBL] [Abstract][Full Text] [Related]
24. Biodiscovery from rare actinomycetes: an eco-taxonomical perspective. Kurtböke DI Appl Microbiol Biotechnol; 2012 Mar; 93(5):1843-52. PubMed ID: 22297430 [TBL] [Abstract][Full Text] [Related]
25. Marine Actinomycetes, New Sources of Biotechnological Products. Jagannathan SV; Manemann EM; Rowe SE; Callender MC; Soto W Mar Drugs; 2021 Jun; 19(7):. PubMed ID: 34201951 [TBL] [Abstract][Full Text] [Related]
26. Genus Streptomyces: Recent advances for biotechnological purposes. de Lima Júnior AA; de Sousa EC; de Oliveira THB; de Santana RCF; da Silva SKR; Coelho LCBB Biotechnol Appl Biochem; 2023 Aug; 70(4):1504-1517. PubMed ID: 36924211 [TBL] [Abstract][Full Text] [Related]
27. The Diversity, Metabolomics Profiling, and the Pharmacological Potential of Actinomycetes Isolated from the Estremadura Spur Pockmarks (Portugal). Pinto-Almeida A; Bauermeister A; Luppino L; Grilo IR; Oliveira J; Sousa JR; Petras D; Rodrigues CF; Prieto-Davó A; Tasdemir D; Sobral RG; Gaudêncio SP Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049876 [TBL] [Abstract][Full Text] [Related]
28. Discovering the secondary metabolic potential of Saccharothrix. Wei B; Luo X; Zhou ZY; Hu GA; Li L; Lin HW; Wang H Biotechnol Adv; 2024; 70():108295. PubMed ID: 38052345 [TBL] [Abstract][Full Text] [Related]
30. Development of a drug discovery approach from microbes with a special focus on isolation sources and taxonomy. Igarashi Y J Antibiot (Tokyo); 2023 Jul; 76(7):365-383. PubMed ID: 37188757 [TBL] [Abstract][Full Text] [Related]
31. Discovery and molecular engineering of sugar-containing natural product biosynthetic pathways in actinomycetes. Oh TJ; Mo SJ; Yoon YJ; Sohng JK J Microbiol Biotechnol; 2007 Dec; 17(12):1909-21. PubMed ID: 18167436 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activities of actinomycetes isolated from unexplored regions of Sundarbans mangrove ecosystem. Sengupta S; Pramanik A; Ghosh A; Bhattacharyya M BMC Microbiol; 2015 Aug; 15():170. PubMed ID: 26293487 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological Potential of Phylogenetically Diverse Actinobacteria Isolated from Deep-Sea Coral Ecosystems of the Submarine Avilés Canyon in the Cantabrian Sea. Sarmiento-Vizcaíno A; González V; Braña AF; Palacios JJ; Otero L; Fernández J; Molina A; Kulik A; Vázquez F; Acuña JL; García LA; Blanco G Microb Ecol; 2017 Feb; 73(2):338-352. PubMed ID: 27614749 [TBL] [Abstract][Full Text] [Related]
35. The genus Nonomuraea: A review of a rare actinomycete taxon for novel metabolites. Sungthong R; Nakaew N J Basic Microbiol; 2015 May; 55(5):554-65. PubMed ID: 24633812 [TBL] [Abstract][Full Text] [Related]
36. Diversity, bioactivities, and metabolic potentials of endophytic actinomycetes isolated from traditional medicinal plants in Sichuan, China. Qiu P; Feng ZX; Tian JW; Lei ZC; Wang L; Zeng ZG; Chu YW; Tian YQ Chin J Nat Med; 2015 Dec; 13(12):942-53. PubMed ID: 26721714 [TBL] [Abstract][Full Text] [Related]
37. [Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes]. Orlova TI; Bulgakova VG; Polin AN Antibiot Khimioter; 2015; 60(7-8):47-59. PubMed ID: 26863742 [TBL] [Abstract][Full Text] [Related]
38. Response of Secondary Metabolism of Hypogean Actinobacterial Genera to Chemical and Biological Stimuli. Covington BC; Spraggins JM; Ynigez-Gutierrez AE; Hylton ZB; Bachmann BO Appl Environ Microbiol; 2018 Oct; 84(19):. PubMed ID: 30030223 [TBL] [Abstract][Full Text] [Related]
39. Eliciting antibiotics active against the ESKAPE pathogens in a collection of actinomycetes isolated from mountain soils. Zhu H; Swierstra J; Wu C; Girard G; Choi YH; van Wamel W; Sandiford SK; van Wezel GP Microbiology (Reading); 2014 Aug; 160(Pt 8):1714-1725. PubMed ID: 24794971 [TBL] [Abstract][Full Text] [Related]
40. [Application of molecular biology for the discovery of biosynthetic genes of polyketide and peptide antibiotics produced by actinomycetes]. Kotowska M Postepy Biochem; 2005; 51(3):345-52. PubMed ID: 16381179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]